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Abstract. Although chemical synthesis of galantamine is 
feasible, plants are still the main sources of production for 
this natural product. Galantamine, a reversible acethylcho-
linesterase inhibitor, has been used for decades for various 
medicinal purposes. More recently, it has been successfully 
applied to the treatment of symptoms in Alzheimer’s dis-
ease. Generally, sources for galantamine isolation are the 
plants of Amaryllidaceae family, usually from the Leucojum 
and Narcissus genus. The bulbs of Leucojum aestivum L., 
known in Albania as “zambaku i kënetës” or “bilbilbardha”, 
are used for galantamine isolation. Leucojum is included in 
the IUCN Red List of endangered species. It is known for the 
diversity of alkaloid fraction, dependent on genotype and 
geographical position. Our study aims to investigate alka-
loid fraction, with a focus on the galantamine content in 
the bulbs of Leucojum aestivum L. populations, grown near 
the Buna river banks. The samples were collected during 
two different periods of vegetation: bloom and fructifica-
tion. Thin layer chromatography and high performance liq-
uid chromatography were the analytical techniques used 
for the qualitative and quantitative determination. The 
number of alkaloids detected in different bulb extracts was 
eight, with galantamine as the dominant compound. The 
linearity of HPLC method was checked by injecting solu-
tions containing 20 up to 320 µg/ml of galantamine. The 
average galantamine content was found to be respectively 
0.13% and 0.14% for samples M1 and M2, with reference to 
the dried material. 
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Introduction. Leucojum aestivum L. (summer snowflake), a 
plant species of Amaryllidaceae family, known as “zambaku i 
kënetës” or “bilbilbardha”, grows in wet environment [1]. In Al-
bania the natural habitats are: the Buna river delta, the Derven-
Krujë zone and the outskirts of the village Gjergjevicë, near the 
mountain Ostrovicë. The plant is considered as an endangered 
plant species [2]. For decades the bulbs of L. aestivum have 
been used as a valuable source for the industrial isolation of the 
alkaloid. Galantamin was first isolated in 1952 from Galantus 
woronowii. The pharmacological properties soon attracted the 
attention of the pharmaceutical industry. Due to their small size 
and the variability of galantamine content, Galantus species 
were soon replaced by L. aestivum [3]. Although the chemical 
synthesis of galantamine has been achieved, plant material re-
mains the main source for galantamin isolation. In Europe now-
adays it is being extracted from Leucojum aestivum and from 
Narcissus cultivars [4]. Depending on the geographical position 
and the plant genotype, the alkaloid pattern as well as the 
galantamine content and its percentage in the alkaloid mixture, 
varies widely [5, 6]. In relation to the geographical location of 
the populations distributed along Balkan peninsula, Leucojum 
aestivum alkaloid profile is dominated by galantamin, lycorine 
or hemantamin. The production cost of galantamine is deter-
mined by the quality of plant raw material. One of the first 
products of the pharmaceutical industry was traded under the 
name of “Nivalin” (Sopharma). 
Galantamine has been used for decades for various indications 
such as the treatment of poliomyelitis, myasthenia gravis and 
other neuromuscular disorders. [7]. Galantamin is a long acting, 
selective, reversible and competitive acetylcholinesterase inhibi-
tor, marketed as a hydrobromide salt [8, 9]. Currently galanta-
mine is used for the treatment of mild to moderate Alzheimer’s 
disease. It allows levels of acetylcholine to be increased in the 
parts of the brain associated with intellectual function. Galan-
tamin hydrobromide is one of the three acethylcholinesterase 
inhibitors approved by regulatory agencies EMA and FDA for 
the symptomatic treatment of Alzheimer’s disease, together 
with donepezil and rivastigmine. [10, 11]. Recently the mono-
graphs of galantamine hydrobromide have been included in the 
new editions of official pharmacopoeias (USP 2011, Ph. Eur 7). 
There are numerous studies relating to the evaluation of L. aes-
tivum alkaloid pattern, especially to the galantamine assess-
ment. Hyphened instrumental techniques have been applied for 
the compounds characterization [12, 13, 14, 15].  
Although L. aestivum represents a medicinal plant of special 
importance, for the populations grown in Albania only few 
studies have been carried out, dated years ago. The species was 
briefly described in the book “Përcaktues Bimësh”, published in 
1979 [2]. Regarding the chemistry of the plant, the only study 
which chiefly deals with galantamine isolation was published in 
the periodical press of the year 1967 [16].  
Herein we report the results of our study on the identification 
and quantitative assessment of galantamine in the bulbs of 
Leucojum aestivum L. populations grown near the Buna river 
banks.  
 
Matherial and Methods. Plant material Samples were collect-
ed in the first week of April (at the flowering stage: M2) and by 
the end of June (during the fructification: M1), in the years 2013, 
2014 and 2015. A voucher specimen of the species was deposit-
ed in the National Herbarium of Tirana University. After washing 
with running water and removal of foreign parts, the separated 
bulbs were cut in thin slices (Fig. 1 A). The plant material was 
dried at room temperature, protected from sun. The leaves were 
treated in the same manner. Alkaloid extraction 1 g powdered 
dry plant material (sieve 500) was mixed in a covered glass dish 
with 25 ml methanol and left for maceration for 24 hours. Ex-
traction was carried out in an ultrasonic bath, for 15 minutes. 
The sonication procedure was repeated for another 15 minutes. 
After centrifugation, the plant residues were rinsed with 5 ml 
methanol and the combined extracts were evaporated under 
vacuum. The dry extract was dissolved in 4 ml of 3% sulfuric 
acid and defatted with diethyl ether (3 x 5 ml) in a separating 
funnel. After basification to pH 9-10 with 25% ammonia, the 
alkaloids were extracted with chloroform (3 x 5 ml). The com-
bined chloroform layers were dried over a small quantity of 
anhydrous sodium sulphate and evaporated to dryness. The 
obtained dried alkaloid fraction was dissolved in 1 ml methanol 
for further TLC and HPLC analysis (a). Thin layer chromatog-
raphy (TLC). An aliquot of 10 µl of sample solution (a) and 10 
µl of galantamine hydrobromide standard solution (2.5 mg/ml) 
were spotted on a silica gel 60 F254 pre-coated plate (10 x 20 
cm, 0.2 mm layer) and were developed with the mixture chloro-
form : methanol (8:2) - migration distance 10 cm. After the sol-
vents evaporation at room temperature, the plate was examined 
under the UV light, at 254 nm. Alkaloid compounds were visual-
ized after spraying with Dragendorff’s reagent [17].  Pre-coted 
plates and the reagents were Merck products. The reference 
substance used was galantamine hydrobromide (Martin Bauer, 
PhytoLab – Germany). High performance liquid chromatog-
raphy (HPLC). Equipment: HPLC analysis system Shimadzu. 
Software: LabSolution, detector DAD, auto sampler: Sil-20A. 
The chromatographic assay was performed on a Lichrosorb C18 
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column (250 x 4.6 mm) reversed phase matrix (5 µm), column 
temperature: 300C. Isocratic elution was carried out with the 
mobile phase acetonitrile: methanol: buffer pH 4.5 (10: 10: 80), 
flow rate: 1 ml/min. Detector was set at 230 nm. [18]. Volume of 
injection was 20 µl. Buffer solution: in a volumetric dish of 1L, 
1 ml triethylamine was mixed with the solution of 3.45 g/L 
monobasic sodium phosphate in water and filled with the same 
solution up to the mark. pH was adjusted with phosphoric acid 
to pH 4.5.  Standard stock solution with the concentration of 16 
mg/ml galantamine in methanol (10.2 mg galantamine hydro-
bromide in 50 ml methanol), was diluted several times to obtain 
the concentrations of 20, 40, 80, 160 and 320 µg/ml. The num-
ber of replications at each calibration level was four.  
Sample solutions (a) from M1 and M2 were diluted four times 
before being injected. Galantamin identification in sample solu-
tion was carried out by comparison of retention time, while the 
quantitative evaluation of it by measuring the surface under the 
corresponding peak. 
 
Results and Disscussions. In the above TLC experimental con-
ditions, after twice repeated migration, a good separation of 
galantamine from the other alkaloid compounds was achieved. 
Observed under UV light, as well as after visualization with Dra-
gendorff’s reagent, the spot of galantamine (Rf 0.58) in both 
chromatograms M1 and M2 was the main component (Fig.1B). 
Alkaloid patterns were similar in both analyzed samples, show-
ing eight separated alkaloids. Considering the color intensity 
and the spot size, another alkaloid (Rf 0.32) seemed to be in 
relatively large quantities, especially in the chromatogram M2. 
On a second plate were spotted aliquots of 20 µl, as well as the 
methanol extract of leaves prepared in the same manner (G). 
When TLC chromatograms were examined under UV light, 
galantamine was visible on the chromatogram G, but in smaller 
quantities compared with M1 and M2. There were also few of 
the other alkaloid constituents.   
Among the HPLC chromatographic systems proven on the 
galantamine separation from the other constituents present in 
the herbal extracts, good results were achieved applying the 
system described by the USP 2012 for the dissolution test of 
galantamine tablets. The HPLC chromatogram of the standard 
solution is given in Fig 2A, while in Fig 2B the chromatogram of 
plant extract, where a well separated galantamine could be 
seen (retention time of 6.5 min.). The relative standard devia-
tion for the standard solution injected several times was about 
0.2%. The calibration curve (Fig. 3) showed linearity in concen-
trations between 20 – 320 µg/ml galantamine, with a correla-
tion factor 0.9998.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 A) L. aestivum bulbs. B) TLC chromatograms. Galanta-
mine,  lane 1 L. aestivum extracts M1 in lane 2 and M2 in lane 3)        
 
It remains to be verified, however considering the relative re-
tention time of galantamine versus the peak with the retention 
time 3.7 min. and comparing it with values given by other au-
thors (in similar HPLC systems) [19, 20], it is probable that the 
peak belongs to lycorine. 
Sample M1 and M2 general parameters resulted as follows. The 
average loss on drying was 9.5% and 10.8% respectively, these 
values were taken into consideration in calculations. The mean 
values for the total ash were also close:  6.2% and 6.5%.  
The average galantamine content in bulbs from plants collected 
in April (M1) and those collected in June (M2) does not vary 
widely, it was found to be 0.13% and 0.14%, with reference to 
the dried substance. 
Generally, the average galantamine content in Leucojum aes-
tivum populations gathered from natural habitats and used for 
industrial production was found to vary from 0.1 - 0.2% (dry 
substance) [5]. Investigations on L. aestivum plants grown in the 
Balkan peninsula have revealed chemodiversity in both alkaloid 
patterns and galantamine content. In relation to their origin, 
the alkaloid pattern can be dominated by galantamine, lycorine 
or haemanthamine. The average galantamine content in sum-
mer snowflake bulbs varied from traces to 0.3%, also the galan-
tamine percentage in the total alkaloid mixture ranged from 4 
to 99% [5, 6]. The relatively heigh content of galantamine in 
Leucojum aestivum bulbs in the study, as well as the domina-
tion of galantamine in the alkaloid mixture, makes the plant 
material suitable for the industrial production of galantamine. 
The results suggest the need for further agro-biological and 
chemical studies on L. aestivum populations grown in Albania.  
Due to the diversity of alkaloid content in Amaryllidaceae spe-
cies [21, 22] and a remarkable increased demand for galanta-
mine in the last few years [23], the European Council approved 
the project “SUPROGAL” with international participation, to 
support the research on high - galantamine producing plants. 
The plants Leucojum aestivum and Narcissus confusus have 
been previously selected [24]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. HPLC chromatograms of Galantamine standard solution 
panel A and L. aestivum plant extract panel B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Calibration curve used for Galantamine quantification 
extracted from L. aestivum. 
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Conclusions The plant, collected in a small island near the Buna 
river banks, was identified as Leucojum aestivum L. 
(Amaryllidaceae), because of macroscopic characteristics and 
the alkaloid galantamine presence. TLC chromatograms of 
methanol extracts from plant bulbs showed eight well separated 
alkaloids, with the galantamine as the main component. Galan-
tamine was identified also in the leaf extracts. The application of 
high performance liquid chromatography, using the mixture 
acetonitrile : methanol : buffer 4.5 (10:10:80) as mobile phase 
and the C18 column, led to an efficient separation of galanta-
mine from the other compounds present in the extracts. The 
calibration curve showed linearity from 20 to 320 µg/ml, with 
correlation factor 0.9998. The estimated galantamine content in 
bulbs from plants gathered in two different periods of vegeta-
tion, bloom and fructification, did not vary widely. The average 
galantamine content was found to be 0.14 and 0.13% respec-
tively, with reference to the dried substance. Given the special 
value of Leucojum aestivum as plant raw material for galanta-
mine isolation as well as growing market demand, we propose 
further studies in the natural habitats where the plant grows.  
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